EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, cilt.24, sa.9, ss.1012-1019, 2012 (SCI-Expanded)
Objective Peginterferon (PEG-IFN) is considered as a first-line treatment option for hepatitis B e antigen (HBeAg)-negative chronic hepatitis B. We aimed to evaluate the long-term response to PEG-IFN in HBeAg-negative patients.